Nigeria vs Togo: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Nigeria
53.0%
in 2025
Togo
58.0%
in 2025
Nigeria rank
11th
Togo rank
10th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Nigeria
- Togo
How they compare
Togo currently reports 58.0% against 53.0% in Nigeria, a difference of 5.0%.
That makes Togo's figure about 1.1 times Nigeria's.
The two have swapped places 2 times across 10 shared years of data; in 2016 it was Togo ahead.
Nigeria ranks 11th and Togo ranks 10th of 26 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nigeria | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.5% | 0.0% | 5.5% | Nigeria |
| 2020s | 51.0% | 37.7% | 13.3% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Nigeria or Togo?
- Togo, at 58.0% against 53.0% in Nigeria as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Nigeria and Togo?
- 5.0%, with Togo ahead.
- How many years of comparable data are there for Nigeria and Togo?
- 10 years are reported by both, from 2016 to 2025.
- How do Nigeria and Togo rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Nigeria ranks 11th and Togo ranks 10th of 26 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.